FDA framework outlines the future of 3D printing in healthcare

As the technology enters uncharted territory as a common practice, the FDA agency releases guidance to encourage safe and effective innovation.

As innovative providers and clinicians begin using 3D printing to create custom prosthetics, implants and medical devices, it can feel like the additive manufacturing health revolution is already in place. But with techniques such as bioprinting, which pertains to biological, cellular and tissue-based products, and custom-printed pharmaceuticals still on the horizon alongside hundreds of other undiscovered uses, the health industry is only just dipping its toes in the waters of what 3D printing can achieve.

To help frame the future of 3D printing in the healthcare industry, the Food and Drug Administration has released detailed guidance for 3D printer manufacturers.